Targeting AML at the intersection of epigenetics and signaling (2022)
Attributed to:
Elucidation of cellular and molecular mechanisms of lymphoma induction and evolution to identify therapeutic targets
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scisignal.abo0059
PubMed Identifier: 35439022
Publication URI: http://europepmc.org/abstract/MED/35439022
Type: Journal Article/Review
Parent Publication: Science Signaling
Issue: 730
ISSN: 1945-0877